It is a broadly described annual report of Biocon Limited in the year of 2016-2017. During the financial year, Total assets of the Company stood at Rs. 93,942 million. The Company’s revenues registered a growth of 18% to Rs. 40,787 million from Rs. 34,602 million in FY16. Other income for FY17 at Rs. 988 million (FY16 Rs. 1,731 million), primarily due to foreign exchange gain Rs. 160 million and dividend from subsidiaries Rs. 487 million in FY16. Total expenses of the Company for the year Rs. 32,453 million. The Profit before tax and exceptional items for the year was Rs. 8,497 million as compared to Rs. 7,513 million in 2016. Profit after Tax (PAT) for the year grew by 11% to Rs. 6,121 million from Rs. 5,504 million. Profits of FY17 included a tax on an exceptional income of Rs. 78 million as against an exceptional gain of Rs. 1,483 million (net of taxes) in FY16. The Earnings per share (EPS) of the Company for the year stood at Rs. 31.59.
The Board of Directors of the Company has recommended a final dividend of Rs. 3/- (Pre-Bonus) per equity share on the face value of Rs. 5/- per equity share for the financial year ended 31st March 2017 amounting to Rs. 600 million.
More Annual Report of Biocon Limited:
